Riboflavin metabolism in cancer.
D000255:Adenosine Triphosphate; D000818:Animals; D001391:Azo Compounds / Q000378:metabolism; D002273:Carcinogens / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000378:metabolism* / Q000401:mortality; D005486:Flavin Mononucleotide / Q000378:metabolism; D005182:Flavin-Adenine Dinucleotide / Q000378:metabolism; D006801:Humans; D008113:Liver Neoplasms; D008297:Male; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000150:complications / Q000378:metabolism / Q000401:mortality; D009713:Nucleotidyltransferases / Q000378:metabolism; D051381:Rats; D012256:Riboflavin / Q000378:metabolism; D012257:Riboflavin Deficiency / Q000150:complications / Q000378:metabolism*
D001391:Azo Compounds; D002273:Carcinogens; D005182:Flavin-Adenine Dinucleotide; D005486:Flavin Mononucleotide; D000255:Adenosine Triphosphate; D009713:Nucleotidyltransferases; D012256:Riboflavin